One of the most important steps in the process of developing a medicine is determining its safety. Our company is dedicated to providing pre-clinical drug research services to support our clients' drug development, pre-clinical and clinical investigations, and assist them in deciding which drug candidates are most worthwhile to pursue in clinical trials. We emphasize pharmacology, pharmacokinetics, medication safety assessment, and bioanalytical services in our customized service solutions.
Service Overview
Preclinical studies are research phases that start before clinical trials in the drug development process. It is during these phases that crucial feasibility, iterative testing, and drug safety data are gathered. Different types of preclinical studies may be conducted for each type of product. For instance, medications may be subjected to toxicological, absorption, distribution, metabolism, and excretion (ADME), as well as pharmacodynamic and pharmacokinetic testing. Researchers can determine safe starting doses of medications for use in human clinical trials using this data's uneven growth.
Our company has extensive experience in safety assessment and its preclinical research services include toxicology, pharmacology and efficacy studies, ADME, drug metabolism and pharmacokinetics (DMPK), and bioanalytical solutions for small molecules, biologics, and herbal medicines.
Our services cover the entire development process, including non-clinical in vitro and in vivo studies to investigate the DMPK properties of compounds and to predict the risk of drug-drug interactions (DDI). You can hasten decision-making and cut study costs by using adaptable experimental designs and quick-start studies.
Overall Solutions
We are able to provide support services for a variety of pharmacological analysis projects, including cell level screening services, cell line and model identification, rat/mouse genotyping services, PET-CT services and flow cytometry services.
We have established a system of drug safety evaluation services in line with international standards, including but not limited to single and repeated dose toxicology, safety pharmacology and toxicokinetics.
We design and conduct in vivo and in vitro pharmacokinetic (PK) tests based on customer needs and provide a complete pharmacokinetic evaluation and optimization service for our customers.
Our bioanalytical services cover pharmacokinetics, pharmacodynamics, and immunogens. We can design and conduct a series of bioanalysis services according to the needs of customers, including but not limited to macromolecular drug bioanalysis, small molecule drug bioanalysis, and biomarker analysis.
We can provide one-stop biopharmaceutical R&D outsourcing services that integrate chemistry, biology, pharmacodynamic evaluation, pharmacokinetic evaluation, and toxicological evaluation.
Why Choose Us?
- We have extensive drug discovery and development expertise in small molecules (NCE), biologics, and herbal medicines for any therapeutic modality.
- We have laboratories and facilities that meet international accreditation standards.
- We offer a full range of bioanalytical services and global regulatory affairs to ensure successful IND submissions.
- Our dedicated research scientists with flexible capabilities.
For more information, please feel free to contact us.
Related Services
It should be noted that our service is only used for research, not for clinical use.
